Form 4 for VOR Vor Biopharma Inc.
Accepted 2022-09-15 00:00:00 ET · period of report 2022-09-13 · accession 0001209191-22-050071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-15 | 2022-09-13 | VOR | ANG ROBERT | Pres, CEO, Dir | A - Grant | $0.00 | +172.5K | 584.6K | +42% | $0 |
| D | 2022-09-15 | 2022-09-13 | VOR | ANG ROBERT | Pres, CEO, Dir | A - Grant | $0.00 | +172.5K | 172.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-13 | A | A | 172,500 | $0.00 | 584,572 | D | — | — | (F1) Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in four equal installments on each of March 1, 2023, September 1, 2023, March 1, 2024 and September 1, 2024, in each case, subject to the Reporting Person's continued service as of each such date. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-09-13 | A | A | 172,500 | $0.00 | 172,500 | D | $4.97 · — to 2032-09-12 | 172,500 Common Stock | (F2) The shares shall vest and become exercisable in a series of 24 successive equal monthly installments beginning on October 1, 2022, in each case subject to the Reporting Person's continued service as of each such date. |